Researchers say neuromorphic systems are reaching a “critical juncture,” with scale being a key metric to track the progress ...

A new ML-guided platform can design thousands of new enzymes, predict how they will behave in the real world, and test their ...

Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

Phase 2 randomized study of ELI-002 fully enrolled, with formal interim analysis of disease-free survival (“DFS”) expected in H1 2025; positive results could support rapid advancement into Phase 3 ...

The Clinical Trials Arena spoke to industry experts about what challenges the sector can expect to face in 2025.

Environmental biotechnology is the branch of biotechnology that addresses environmental problems, such as the removal of pollution, renewable energy generation or biomass production, by exploiting ...

On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology equipment, citing national security concerns relating to artificial intelligence ...

The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related ...

Expanded partnership highlights the parties' emerging leadership in targeted alpha therapies (TAT), leveraging Orano Med's expertise in the development of 212 Pb-based TAT and vast proprietary supply ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...